10-Q Filing

Company

Marker Therapeutics, Inc.

Filed

May 15, 2015

Period of Report

March 31, 2015

Accession Number

0001424884-15-000050

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →